Return to Library
Persistent pulmonary hypertension of the newborn Visual Overview
SubcategoryNewborns
Topic

Persistent pulmonary hypertension of the newborn

💡 What You Need to Know

  • Definition: Persistent pulmonary hypertension of the newborn (PPHN) is a condition where the pulmonary vascular resistance (PVR) remains abnormally high after birth, preventing a normal decrease in PVR.
  • Circulatory Failure: This high PVR leads to right-to-left shunting of blood through fetal pathways (foramen ovale and ductus arteriosus), bypassing the lungs and causing severe hypoxemia.
  • Etiology: Often secondary to other neonatal conditions such as meconium aspiration syndrome, sepsis, congenital diaphragmatic hernia, or perinatal asphyxia.
  • Critical Transition: Represents a failure of the normal circulatory adaptation from fetal to neonatal life, where the pulmonary vasculature should dilate to allow for gas exchange.

🤒 Associated Symptoms

  • Cyanosis: Bluish discoloration of the skin, lips, and mucous membranes, often severe and unresponsive to supplemental oxygen.
  • Tachypnea: Abnormally rapid breathing rate, indicating respiratory distress.
  • Retractions: Visible indrawing of the chest wall (subcostal, intercostal, suprasternal) during inspiration.
  • Grunting: An audible expiratory sound caused by partial closure of the glottis to maintain lung volume.
  • Hypoxemia: Persistently low blood oxygen levels, often labile and worsening with handling or crying.
  • Tachycardia: Elevated heart rate, a compensatory response to hypoxemia and stress.
  • Lability: Fluctuations in oxygen saturation and clinical status with minimal stimulation or changes in environment.
  • Heart Murmur: May be present due to tricuspid regurgitation or shunting across the patent ductus arteriosus.

🛡 Crucial Precautions

  • Minimize Stimulation: Handle the infant gently and minimize environmental stimuli (noise, light, excessive touch) to prevent pulmonary hypertensive crises.
  • Avoid Hypoxia and Acidosis: Maintain adequate oxygenation and ventilation to prevent conditions that exacerbate pulmonary vasoconstriction.
  • Temperature Regulation: Ensure strict normothermia to reduce metabolic demand and prevent cold stress, which can worsen PPHN.
  • Fluid Management: Carefully monitor fluid intake and output to prevent fluid overload and pulmonary edema, which can compromise lung function.
  • Sedation and Analgesia: Judicious use of sedatives and analgesics to reduce stress, agitation, and oxygen consumption in intubated infants.
  • Continuous Monitoring: Implement continuous monitoring of oxygen saturation (pre- and post-ductal), blood pressure, and heart rate.
  • Vigilant Observation: Closely observe for signs of clinical deterioration, such as worsening cyanosis, increased work of breathing, or sudden drops in oxygen saturation.

🍽 Dietary Directions & Restrictions

  • NPO Status: Infants with severe PPHN are typically kept nil per os (NPO) initially due to respiratory distress, risk of aspiration, and potential for necrotizing enterocolitis (NEC) in critically ill neonates.
  • Parenteral Nutrition: Intravenous administration of nutrients (total parenteral nutrition - TPN) is initiated early to meet metabolic demands and support growth.
  • Gradual Enteral Feeds: Once the infant is hemodynamically stable and respiratory status improves, minimal enteral (trophic) feeds may be introduced cautiously.
  • Monitoring for Intolerance: Close monitoring for signs of feeding intolerance (e.g., abdominal distension, emesis, gastric residuals) or NEC is crucial during enteral feeding.
  • Breast Milk Preference: If enteral feeding is tolerated, breast milk is the preferred choice due to its immunological and nutritional benefits.

⚠️ Attendant Guidelines

  • Ventilator Management: Adhere strictly to prescribed ventilator settings, aiming for optimal oxygenation and ventilation while minimizing barotrauma and volutrauma.
  • Inhaled Nitric Oxide (iNO): Ensure correct setup, administration, and continuous monitoring of iNO therapy, including methemoglobin levels.
  • Medication Administration: Administer pulmonary vasodilators (e.g., sildenafil), inotropes, and sedatives precisely as ordered, monitoring for therapeutic effects and side effects.
  • Cluster Care: Group nursing interventions to minimize disturbances and allow for periods of uninterrupted rest, reducing stress on the infant.
  • Emergency Preparedness: Be prepared for rapid clinical deterioration, including the need for resuscitation, advanced life support, or escalation to extracorporeal membrane oxygenation (ECMO).
  • Documentation: Maintain meticulous documentation of vital signs, oxygen saturation, ventilator settings, medications, fluid balance, and clinical observations.

🩺 Physician's Perspective

  • Early Diagnosis: Prompt recognition and diagnosis of PPHN, often confirmed by echocardiography, are critical for initiating timely and effective treatment.
  • Multimodal Therapy: Management typically involves a combination of ventilatory support, inhaled nitric oxide (iNO), systemic pulmonary vasodilators, and inotropic support.
  • Address Underlying Cause: Identification and treatment of the primary condition (e.g., sepsis, meconium aspiration syndrome) contributing to PPHN are paramount.
  • Echocardiographic Guidance: Serial echocardiograms are essential to assess the severity of pulmonary hypertension, cardiac function, and the degree of shunting, guiding therapeutic adjustments.
  • ECMO Consideration: For infants with severe, refractory PPHN despite maximal conventional therapy, evaluation for extracorporeal membrane oxygenation (ECMO) should be considered.
  • Neurodevelopmental Follow-up: Long-term neurodevelopmental follow-up is crucial due to the risk of adverse outcomes associated with severe hypoxemia and critical illness.

🎓 Academic & Nursing Corner

  • Fetal Circulation Review: Understand the unique aspects of fetal circulation and the normal transition to neonatal circulation to grasp PPHN pathophysiology.
  • Oxygenation Index (OI): Learn to calculate and interpret the Oxygenation Index as a measure of PPHN severity and a guide for therapeutic escalation.
  • Ventilator Alarms: Familiarize yourself with common ventilator alarms and appropriate troubleshooting steps in neonates with PPHN.
  • iNO Safety Protocols: Understand the principles of inhaled nitric oxide administration, including dosage, weaning, and monitoring for potential side effects like methemoglobinemia.
  • Parental Education: Be prepared to educate and support parents regarding their infant's critical condition, treatment plan, and potential outcomes.
  • Fluid and Electrolyte Balance: Master the principles of meticulous fluid and electrolyte management in critically ill neonates to prevent complications.

🔬 Clinical Reference Index

  • Pulmonary Vascular Resistance (PVR): The resistance to blood flow through the pulmonary arterial system, abnormally high in PPHN.
  • Right-to-Left Shunt: The abnormal flow of deoxygenated blood from the right side of the heart to the left, bypassing the lungs, via the foramen ovale or ductus arteriosus.
  • Inhaled Nitric Oxide (iNO): A selective pulmonary vasodilator that relaxes smooth muscle in the pulmonary vasculature, improving oxygenation.
  • Echocardiogram: An ultrasound of the heart used to diagnose PPHN, assess cardiac function, and quantify pulmonary pressures and shunting.
  • Oxygenation Index (OI): A calculated value (Mean Airway Pressure x FiO2 x 100 / PaO2) used to assess the severity of hypoxemic respiratory failure.
  • Extracorporeal Membrane Oxygenation (ECMO): A form of life support that provides temporary cardiac and/or respiratory assistance by oxygenating blood outside the body.
  • Sildenafil: A phosphodiesterase-5 inhibitor used as a systemic pulmonary vasodilator in some cases of PPHN.
  • Meconium Aspiration Syndrome (MAS): A common underlying cause of PPHN, involving aspiration of meconium into the lungs.